139 related articles for article (PubMed ID: 21922567)
1. Insights into the acid-base properties of Pt(IV)-diazidodiam(m)inedihyroxido complexes from multinuclear NMR spectroscopy.
Ronconi L; Pizarro AM; McQuitty RJ; Sadler PJ
Chemistry; 2011 Oct; 17(43):12051-8. PubMed ID: 21922567
[TBL] [Abstract][Full Text] [Related]
2. Probing platinum azido complexes by 14N and 15N NMR spectroscopy.
Farrer NJ; Gierth P; Sadler PJ
Chemistry; 2011 Oct; 17(43):12059-66. PubMed ID: 21922574
[TBL] [Abstract][Full Text] [Related]
3. Photoactivatable platinum complexes.
Bednarski PJ; Mackay FS; Sadler PJ
Anticancer Agents Med Chem; 2007 Jan; 7(1):75-93. PubMed ID: 17266506
[TBL] [Abstract][Full Text] [Related]
4. Photocytotoxic trans-diam(m)ine platinum(IV) diazido complexes more potent than their cis isomers.
Farrer NJ; Woods JA; Munk VP; Mackay FS; Sadler PJ
Chem Res Toxicol; 2010 Feb; 23(2):413-21. PubMed ID: 19994893
[TBL] [Abstract][Full Text] [Related]
5. Oxidation of 3,6-dioxa-1,8-octanedithiol by platinum(IV) anticancer prodrug and model complex: kinetic and mechanistic studies.
Huo S; Shen S; Liu D; Shi T
J Phys Chem B; 2012 Jun; 116(22):6522-8. PubMed ID: 22574871
[TBL] [Abstract][Full Text] [Related]
6. Kinetics and mechanism for reduction of the anticancer prodrug trans,trans,trans-[PtCl2(OH)2(c-C6H11NH2)(NH3)] (JM335) by thiols.
Lemma K; Shi T; Elding LI
Inorg Chem; 2000 Apr; 39(8):1728-34. PubMed ID: 12526561
[TBL] [Abstract][Full Text] [Related]
7. A computational approach to tuning the photochemistry of platinum(IV) anticancer agents.
Tai HC; Zhao Y; Farrer NJ; Anastasi AE; Clarkson G; Sadler PJ; Deeth RJ
Chemistry; 2012 Aug; 18(34):10630-42. PubMed ID: 22807241
[TBL] [Abstract][Full Text] [Related]
8. Importance of platinum(II)-assisted platinum(IV) substitution for the oxidation of guanosine derivatives by platinum(IV) complexes.
Choi S; Vastag L; Larrabee YC; Personick ML; Schaberg KB; Fowler BJ; Sandwick RK; Rawji G
Inorg Chem; 2008 Feb; 47(4):1352-60. PubMed ID: 18220340
[TBL] [Abstract][Full Text] [Related]
9. Kinetic and equilibria studies of the aquation of the trinuclear platinum phase II anticancer agent [(trans-PtCl(NH(3))(2))(2)(mu-trans-Pt(NH(3))(2)(NH(2)(CH(2))(6)NH(2))(2))](4+) (BBR3464).
Davies MS; Thomas DS; Hegmans A; Berners-Price SJ; Farrell N
Inorg Chem; 2002 Mar; 41(5):1101-9. PubMed ID: 11874344
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, X-ray crystallographic, and NMR characterizations of platinum(II) and platinum(IV) pyrophosphato complexes.
Mishur RJ; Zheng C; Gilbert TM; Bose RN
Inorg Chem; 2008 Sep; 47(18):7972-82. PubMed ID: 18693681
[TBL] [Abstract][Full Text] [Related]
11. A novel isomerization on interaction of antitumor-active azole-bridged dinuclear platinum(II) complexes with 9-ethylguanine. Platinum(II) atom migration from N2 to N3 on 1,2,3-triazole.
Komeda S; Lutz M; Spek AL; Yamanaka Y; Sato T; Chikuma M; Reedijk J
J Am Chem Soc; 2002 May; 124(17):4738-46. PubMed ID: 11971723
[TBL] [Abstract][Full Text] [Related]
12. Reactions of a photoactivatable diazido Pt(iv) anticancer complex with a single-stranded oligodeoxynucleotide.
Liang Z; Lin J; Gong X; Cheng Y; Huang C; Zhang J; Wu X; Wang F; Zhao Y; Wu K
Dalton Trans; 2020 Aug; 49(32):11249-11259. PubMed ID: 32756682
[TBL] [Abstract][Full Text] [Related]
13. Photoactivatable Cell-Selective Dinuclear trans-Diazidoplatinum(IV) Anticancer Prodrugs.
Shi H; Romero-Canelón I; Hreusova M; Novakova O; Venkatesh V; Habtemariam A; Clarkson GJ; Song JI; Brabec V; Sadler PJ
Inorg Chem; 2018 Nov; 57(22):14409-14420. PubMed ID: 30365308
[TBL] [Abstract][Full Text] [Related]
14. trans-Platinum(iv) pro-drugs that exhibit unusual resistance to reduction by endogenous reductants and blood serum but are rapidly activated inside cells:
Chen CKJ; Kappen P; Gibson D; Hambley TW
Dalton Trans; 2020 Jun; 49(23):7722-7736. PubMed ID: 32469362
[TBL] [Abstract][Full Text] [Related]
15. Novel tetracarboxylatoplatinum(IV) complexes as carboplatin prodrugs.
Varbanov HP; Valiahdi SM; Kowol CR; Jakupec MA; Galanski MS; Keppler BK
Dalton Trans; 2012 Dec; 41(47):14404-14415. PubMed ID: 22886297
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and X-ray crystal structure of trans,cis-[Pt(OAc)2I2(en)]: a novel type of cisplatin analog that can be photolyzed by visible light to DNA-binding and cytotoxic species in vitro.
Kratochwil NA; Zabel M; Range KJ; Bednarski PJ
J Med Chem; 1996 Jun; 39(13):2499-507. PubMed ID: 8691447
[TBL] [Abstract][Full Text] [Related]
17. Inversion of the cis geometry requirement for cytotoxicity in structurally novel platinum(II) complexes containing the bidentate N,O-donor pyridin-2-yl-acetate.
Bierbach U; Sabat M; Farrell N
Inorg Chem; 2000 May; 39(9):1882-90. PubMed ID: 11428108
[TBL] [Abstract][Full Text] [Related]
18. Photoactivatable diazido Pt(IV) anticancer complex can bind to and oxidize all four nucleosides.
Cheng Y; Zhang J; Wu K; Gao F; Cheng Y; Zou T; Wu X; Zhao Y; Wang F
Dalton Trans; 2020 Dec; 49(47):17157-17163. PubMed ID: 33244530
[TBL] [Abstract][Full Text] [Related]
19. Relationships between reduction properties and cancer cell growth inhibitory activities of cis-dichloro- and cis-diiodo-Pt(IV)-ethylenediamines.
Kratochwil NA; Bednarski PJ
Arch Pharm (Weinheim); 1999 Aug; 332(8):279-85. PubMed ID: 10489538
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, Structure, and Cytotoxicity of Oxaliplatin-Based Platinum(IV) Anticancer Prodrugs Bearing One Axial Fluoride.
Xu Z; Chan HM; Li C; Wang Z; Tse MK; Tong Z; Zhu G
Inorg Chem; 2018 Jul; 57(14):8227-8235. PubMed ID: 29943979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
